RT Journal
A1 GREEN D
T1 INtravenous immunoglobulin therapy in human immunodeficiency virus—associated thrombocytopenia-reply
JF Archives of Internal Medicine
JO Archives of Internal Medicine
YR 1989
FD February 1
VO 149
IS 2
SP 467
OP 467
DO 10.1001/archinte.1989.00390020151037
UL http://dx.doi.org/10.1001/archinte.1989.00390020151037
AB In Reply.—With regard to Fisher's letter, we agree that outpatient therapy with intravenously administered immunoglobulin is both feasible and less costly than in-hospital treatment for human immunodeficiency virus—associated thrombocytopenia. Indeed, since publication of our article, we have treated some outpatients with intravenously administered immunoglobulin in a dose of 50 g given over a six-hour period as a single infusion, repeating this dose as clinically indicated.